» Articles » PMID: 39157800

The Effect of Progesterone Elevation on the Day of Trigger Administration: A Review of the Literature

Overview
Date 2024 Aug 19
PMID 39157800
Authors
Affiliations
Soon will be listed here.
Abstract

Since the advent of assisted reproductive technology, different variables have been shown to affect pregnancy outcomes. One of the most prevalent studied events is the premature rise in serum progesterone concentrations on the day of trigger administration during cycles of ovarian stimulation. This phenomenon, classically known as premature luteinization, has been observed significantly for decades and has been linked to adverse pregnancy outcomes and lower live birth rates. Ultimately, a quest to find a precise serum progesterone concentration cut-off value that can be effectively used to predict pregnancy outcomes prior to trigger administration is still underway. The purpose of the current research was to study the available literature on the relationship between serum progesterone on the day of trigger administration in controlled ovarian stimulation cycles used for IVF in an attempt to identify a cut-off serum progesterone concentration that can be used to effectively predict future pregnancy outcomes in fresh transfers. This study is a review of the literature and is based on information and data gathered from 36 published articles. The majority of the literature shows that a serum progesterone concentration cut-off of 1.5 (4.77 ) can be used prior to trigger administration to effectively predict pregnancy outcomes. Premature progesterone elevation on the day or prior to the trigger administration is associated with adverse pregnancy outcomes in IVF cycles. Other factors such as follicle number, serum concentration of other hormones, and ovarian response to ovarian stimulation should also be considered to predict the success of IVF protocols.

Citing Articles

The relationship between serum progesterone level on the day of HCG trigger in IVF/ICSI cycles and oocyte maturation and embryo quality: a retrospective observational study.

Hokmabadi E, Salahi E, Ghasemi M BMC Womens Health. 2024; 24(1):673.

PMID: 39736583 PMC: 11684037. DOI: 10.1186/s12905-024-03535-9.

References
1.
Simon C, Martin J, Pellicer A . Paracrine regulators of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000; 14(5):815-26. DOI: 10.1053/beog.2000.0121. View

2.
Lawrenz B, Beligotti F, Engelmann N, Gates D, Fatemi H . Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles. Hum Reprod. 2016; 31(11):2554-2560. DOI: 10.1093/humrep/dew213. View

3.
Hoff J, Quigley M, Yen S . Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab. 1983; 57(4):792-6. DOI: 10.1210/jcem-57-4-792. View

4.
Humaidan P, Polyzos N, Alsbjerg B, Erb K, Mikkelsen A, Elbaek H . GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum Reprod. 2013; 28(9):2511-21. DOI: 10.1093/humrep/det249. View

5.
Esteves S, Khastgir G, Shah J, Murdia K, Gupta S, Rao D . Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in Fertilization/Intracytoplasmic Sperm Injection Cycles. Front Endocrinol (Lausanne). 2018; 9:201. PMC: 5932157. DOI: 10.3389/fendo.2018.00201. View